Neurophet Supplies Brain Imaging Software to Raffles Medical in Singapore

Neurophet announced in a press release that it has signed a supply agreement with Raffles Medical in Singapore for its neurodegenerative brain imaging analysis software, Neurophet AQUA.

Neurophet AQUA performs quantitative analysis of brain MRI scans, allowing clinicians to assess brain atrophy and white matter degeneration. The software measures structural changes associated with neurodegenerative diseases such as Alzheimer's disease and vascular dementia. It generates analysis reports tailored to each patient.

Raffles Medical is part of Raffles Medical Group, which operates more than 100 clinics across Singapore and Asia. The clinics are connected to Raffles Hospital and Raffles Specialist Centres, providing access to diagnostic and specialist services.

Neurophet has previously collaborated with local institutions including the Dementia Research Centre at Nanyang Technological University, the National University of Singapore, and Singapore General Hospital. The company develops AI based diagnostic and treatment support tools for brain disorders, with products including Neurophet SCALE PET, Neurophet tES/TMS LAB, and Neurophet AQUA AD.